Biotech ETFs Rally as Illumina Tops Q2 Expectations
This article was originally published on ETFTrends.com.
Biotechnology sector ETFs were among the best performers Tuesday, with Illumina (NasdaqGS: ILMN) shares surging after the genomics firm beat second-quarter expectations and raised its year-end outlook. Among the best performing ETFs of Tuesday, the Invesco Dynamic Biotech & Genome (NYSEArca:PBE) increased 3.0%, ARK Genomic Revolution Multi-Sector ETF (NYSEArca: ARKG) advanced 2.5% and iShares Nasdaq [...]